28.10.2010 • NewsDuPontQ3 2010

DuPont Quarterly Profit Beats Street

DuPont posted a higher-than-expected quarterly profit as sales rose in all six business units and across the globe.

During the third quarter, the company earned $367 million, or 40 cents per share, compared with $409 million, or 45 cents per share, a year earlier.

Analysts on average expected earnings of 34 cents per share, according to Thomson Reuters I/B/E/S.

Revenue rose 14.8% to $7 billion. Analysts expected $6.72 billion.

For 2010, DuPont now expects to earn $3.10 per share, excluding items, up from a previous estimate of $2.90 to $3.05. Analysts were expecting $3.04.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.